Press "Enter" to skip to content

Self-Monitoring Blood Glucose Market 2019 Significant Growth Rate by Industry Size, Share, Market Dynamics, Development Status of Key Players Forecast to 2024

Self-Monitoring

The “Self-Monitoring Blood Glucose Market” research report 2019-2024 delivers comprehensive information and valuable insights about the Self-Monitoring Blood Glucose industry. The information available in the Self-Monitoring Blood Glucose market report is not only based on the facts but also on the case studies, which analysts have included to convey appropriate information to the clients in a well-versed manner. Self-Monitoring Blood Glucose market report includes valuable information to assist new entrants, as well as established players, to understand the prevailing trends in the market.

Some Companies Are Covered in the Self-Monitoring Blood Glucose Market:

  • Abbott Diabetes Care
  • Roche
  • Johnson & Johnson
  • Arkray
  • Ascensia Diabetes Care
  • Agamatrix Inc.
  • Bionime Corporation
  • Acon
  • Medisana
  • Trivida
  • Rossmax

    Get a Sample Copy of the Report – https://www.industryresearch.co/enquiry/request-sample/13999776

    Market Overview:

  • One of the fastest-growing chronic diseases in the world is diabetes. Diabetes is a disease that occurs when the glucose levels of the body increase to more than the normal level, and the body unable to produce insulin. Hence, glucometers are used to monitor glucose levels. The Type 1 diabetes population around the world is rising while witnessing a CAGR of 2.13%. As the diabetic population rises, the self-monitoring blood glucose devices market is also bound to increase.
  • Other factors, such as technological innovations, the convenience of conventional glucose monitoring over conventional monitoring, and early detection of hypo- and hyperglycemic diabetes are the major drivers for market growth.

    Scope of the Report:

  • The report includes a complete study on self-monitoring blood glucose, which includes glucometer devices, blood glucose test strips, and lancets. The study is further divided into hospital usage and home usage.

    Reasons for Buying Self-Monitoring Blood Glucose Market Report:

    • This report provides pin-point analysis for changing competitive dynamics
    • It provides a forward looking perspective on different factors driving or restraining market growth
    • It provides a five-year forecast assessed on the basis of how the market is predicted to grow
    • It helps in understanding the key product segments and their future
    • It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
    • It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments

    For More Information or Query or Customization Before Buying, Visit at – https://www.industryresearch.co/enquiry/pre-order-enquiry/13999776

    Key Market Trends: – Most of the Glucometer Market Revenue is Generated from Blood Glucose Test Strips.

    Glucometer is considered to be a one-time purchase. However, test strips, on the other hand, are considered to be a continuous investment, as a test strip needs to be disposed off after one use. Thus, it presents a considerable cost impact to the consumers.
    Overall, the global demand for blood glucose test strips is projected to witness significant growth over the forecast period. The growth of the market studied is expected to be spurred by the rising global diabetic population.
    The growth in market volumes and share of the test strip is expected to be better than that of glucometers, because of the difference in the use-case frequency. While an average glucose meter lasts anywhere between six months and three years, presenting a one-time cost, during the same time frame, the corresponding use of multiple (in the range of thousands) test strips may occur, causing a recurrent cost impact.

    North America has the Largest Market Share, and will Continue to Do So in the Future

    The global self-monitoring blood glucose systems market is currently experiencing a boost because diabetic patients have to test their glucose levels throughout the day. Mainly Type 1 diabetic people must, and should, test their blood glucose at least three times per day to take their insulin dosage.
    The countries in the North American region have a high prevalence of diabetes. According to WHO in 2015, approximately 1.6 million deaths were attributed directly to diabetes on a global scale. An additional 2.2 million deaths were caused due to high blood glucose in 2012.
    According to the ADA (American Diabetes Association), the total assessed cost for diagnosed diabetes in 2017 was USD 327 billion, which was inclusive of USD 237 billion in direct medical costs and USD 90 billion in augmented productivity.
    The prevalence of diabetes has increased dramatically during the past two decades, which is a fact driven by the increased prevalence of obesity and lifestyle changes. Diabetes ranks among the fast-growing chronic diseases in the United States.

    Self-Monitoring Blood Glucose Market Report Provides Comprehensive Analysis of:

    • Functional market industry outline
    • Up and downstream industry examination
    • Channels and propositions believability
    • Market challenge by key players
    • Enhancement suggestions examination

    Purchase this Report (Price 5000 USD for single user license) – https://www.industryresearch.co/purchase/13999776

    Report Highlights:

    • Market Dynamics – Drivers, Restraints, and Opportunities
    • Market Segmentation – Types, Applications, Regions, and Technology
    • Market Trends
    • Competitive Landscape
    • SWOT Analysis and Porter’s Five Forces Analysis

    Detailed TOC of Self-Monitoring Blood Glucose Market Report 2019-2024:

    1 INTRODUCTION
    1.1 Study Deliverables
    1.2 Study Assumptions
    1.3 Scope of the Study

    2 RESEARCH METHODOLOGY

    3 EXECUTIVE SUMMARY

    4 MARKET DYNAMICS
    4.1 Market Overview
    4.2 Drivers
    4.3 Restraints
    4.4 Porter’s Five Forces Analysis
    4.4.1 Bargaining Power of Suppliers
    4.4.2 Bargaining Power of Consumers
    4.4.3 Threat of New Entrants
    4.4.4 Threat of Substitute Products and Services
    4.4.5 Intensity of Competitive Rivalry

    5 MARKET SEGMENTATION
    5.1 Self-blood Glucose Monitors
    5.1.1 By Component (Market Size, Value, and Volume)
    5.1.1.1 Glucometer Devices
    5.1.1.2 Test Strips
    5.1.1.3 Lancets
    5.1.2 By End User
    5.1.2.1 Hospital USE (Market Size, Value, and Volume)
    5.1.2.1.1 Glucometer Devices
    5.1.2.1.2 Test Strips
    5.1.2.1.3 Lancets
    5.1.2.2 Personal Use (Market Size, Value, and Volume)
    5.1.2.2.1 Glucometer Devices
    5.1.2.2.2 Test Strips
    5.1.2.2.3 Lancets
    5.2 Geography
    5.2.1 North America
    5.2.1.1 United States (Market Size, Value, and Volume)
    5.2.1.1.1 By Component (Glucometer Devices, Test Strips, and Lancets)
    5.2.1.1.2 By End User (Hospital Use and Home Use)
    5.2.1.1.3 By Company (Roche, Abbott, Johnson & Johnson, and Others)
    5.2.1.2 Canada (Market Size, Value, and Volume)
    5.2.1.2.1 By Component (Glucometer Devices, Test Strips, Lancets)
    5.2.1.2.2 By End User (Hospital Use and Home Use)
    5.2.1.2.3 By Company (Roche, Abbott, Johnson & Johnson, and Others)
    5.2.1.3 Rest of North America(Market Size, Value, and Volume)
    5.2.1.3.1 By Component (Glucometer Devices, Test Strips, and Lancets)
    5.2.1.3.2 By End User (Hospital Use and Home Use)
    5.2.1.3.3 By Company (Roche, Abbott, Johnson & Johnson and Others)
    5.2.2 Europe
    5.2.2.1 France (Market Size, Value, and Volume)
    5.2.2.1.1 By Component (Glucometer Devices, Test Strips, and Lancets)
    5.2.2.1.2 By End User (Hospital Use and Home Use)
    5.2.2.1.3 By Company (Roche, Abbott, Johnson & Johnson and Others)
    5.2.2.2 Germany (Market Size, Value, and Volume)
    5.2.2.2.1 By Component (Glucometer Devices, Test Strips, and Lancets)
    5.2.2.2.2 By End User (Hospital Use and Home Use)
    5.2.2.2.3 By Company (Roche, Abbott, Johnson & Johnson and Others)
    5.2.2.3 Italy (Market Size, Value, and Volume)
    5.2.2.3.1 By Component (Glucometer Devices, Test Strips, and Lancets)
    5.2.2.3.2 By End User (Hospital Use and Home Use)
    5.2.2.3.3 By Company (Roche, Abbott, Johnson & Johnson and Others)
    5.2.2.4 Spain (Market Size, Value, and Volume)
    5.2.2.4.1 By Component (Glucometer Devices, Test Strips, and Lancets)
    5.2.2.4.2 By End User (Hospital Use and Home Use)
    5.2.2.4.3 By Company (Roche, Abbott, Johnson & Johnson and Others)
    5.2.2.5 United Kingdom(Market Size, Value, and Volume)
    5.2.2.5.1 By Component (Glucometer Devices, Test Strips, and Lancets)
    5.2.2.5.2 By End User (Hospital Use and Home Use)
    5.2.2.5.3 By Company (Roche, Abbott, Johnson & Johnson and Others)
    5.2.2.6 Russia(Market Size, Value, and Volume)
    5.2.2.6.1 By Component (Glucometer Devices, Test Strips, and Lancets)
    5.2.2.6.2 By End User (Hospital Use and Home Use)
    5.2.2.6.3 By Company (Roche, Abbott, Johnson & Johnson and Others)
    5.2.2.7 Rest of Europe (Market Size, Value, and Volume)
    5.2.2.7.1 By Component (Glucometer Devices, Test Strips, and Lancets)
    5.2.2.7.2 By End User (Hospital Use and Home Use)
    5.2.2.7.3 By Company (Roche, Abbott, Johnson & Johnson and Others)
    5.2.3 Latin America
    5.2.3.1 Mexico (Market Size, Value, and Volume)
    5.2.3.1.1 By Component (Glucometer Devices, Test Strips, and Lancets)
    5.2.3.1.2 By End User (Hospital Use and Home Use)
    5.2.3.1.3 By Company (Roche, Abbott, Johnson & Johnson and Others)
    5.2.3.2 Brazil(Market Size, Value, and Volume)
    5.2.3.2.1 By Component (Glucometer Devices, Test Strips, and Lancets)
    5.2.3.2.2 By End User (Hospital Use and Home Use)
    5.2.3.2.3 By Company (Roche, Abbott, Johnson & Johnson and Others)
    5.2.3.3 Rest of Latin America (Market Size, Value, and Volume)
    5.2.3.3.1 By Component (Glucometer Devices, Test Strips, and Lancets)
    5.2.3.3.2 By End User (Hospital Use and Home Use)
    5.2.3.3.3 By Company (Roche, Abbott, Johnson & Johnson and Others)
    5.2.4 Asia-Pacific
    5.2.4.1 Japan (Market Size, Value, and Volume)
    5.2.4.1.1 By Component (Glucometer Devices, Test Strips, and Lancets)
    5.2.4.1.2 By End User (Hospital Use and Home Use)
    5.2.4.1.3 By Company (Roche, Abbott, Johnson & Johnson and Others)
    5.2.4.2 South Korea (Market Size, Value, and Volume)
    5.2.4.2.1 By Component (Glucometer Devices, Test Strips, and Lancets)
    5.2.4.2.2 By End User (Hospital Use and Home Use)
    5.2.4.2.3 By Company (Roche, Abbott, Johnson & Johnson and Others)
    5.2.4.3 China (Market Size, Value, and Volume)
    5.2.4.3.1 By Component (Glucometer Devices, Test Strips, and Lancets)
    5.2.4.3.2 By End User (Hospital Use and Home Use)
    5.2.4.3.3 By Company (Roche, Abbott, Johnson & Johnson and Others)
    5.2.4.4 India (Market Size, Value, and Volume)
    5.2.4.4.1 By Component (Glucometer Devices, Test Strips, and Lancets)
    5.2.4.4.2 By End User (Hospital Use and Home Use)
    5.2.4.4.3 By Company (Roche, Abbott, Johnson & Johnson and Others)
    5.2.4.5 Australia (Market Size, Value, and Volume)
    5.2.4.5.1 By Component (Glucometer Devices, Test Strips, and Lancets)
    5.2.4.5.2 By End User (Hospital Use and Home Use)
    5.2.4.5.3 By Company (Roche, Abbott, Johnson & Johnson and Others)
    5.2.4.6 Vietnam (Market Size, Value, and Volume)
    5.2.4.6.1 By Component (Glucometer Devices, Test Strips, and Lancets)
    5.2.4.6.2 By End User (Hospital Use and Home Use)
    5.2.4.6.3 By Company (Roche, Abbott, Johnson & Johnson and Others)
    5.2.4.7 Malaysia (Market Size, Value, and Volume)
    5.2.4.7.1 By Component (Glucometer Devices, Test Strips, and Lancets)
    5.2.4.7.2 By End User (Hospital Use and Home Use)
    5.2.4.7.3 By Company (Roche, Abbott, Johnson & Johnson and Others)
    5.2.4.8 Indonesia( Market Size, Value, and Volume)
    5.2.4.8.1 By Component (Glucometer Devices, Test Strips, and Lancets)
    5.2.4.8.2 By End User (Hospital Use and Home Use)
    5.2.4.8.3 By Company (Roche, Abbott, Johnson & Johnson and Others)
    5.2.4.9 Philippines (Market Size, Value, and Volume)
    5.2.4.9.1 By Component (Glucometer Devices, Test Strips, and Lancets)
    5.2.4.9.2 By End User (Hospital Use and Home Use)
    5.2.4.9.3 By Company (Roche, Abbott, Johnson & Johnson and Others)
    5.2.4.10 Thailand (Market Size, Value, and Volume)
    5.2.4.10.1 By Component (Glucometer Devices, Test Strips, and Lancets)
    5.2.4.10.2 By End User (Hospital Use and Home Use)
    5.2.4.10.3 By Company (Roche, Abbott, Johnson & Johnson and Others)
    5.2.4.11 Rest of Asia-Pacific (Market Size, Value, and Volume)
    5.2.4.11.1 By Component (Glucometer Devices, Test Strips, and Lancets)
    5.2.4.11.2 By End User (Hospital Use and Home Use)
    5.2.4.11.3 By Company (Roche, Abbott, Johnson & Johnson and Others)
    5.2.5 Middle East & Africa
    5.2.5.1 Saudi Arabia (Market Size, Value, and Volume)
    5.2.5.1.1 By Component (Glucometer Devices, Test Strips, and Lancets)
    5.2.5.1.2 By End User (Hospital Use and Home Use)
    5.2.5.1.3 By Company (Roche, Abbott, Johnson & Johnson and Others)
    5.2.5.2 Iran (Market Size, Value, and Volume)
    5.2.5.2.1 By Component (Glucometer Devices, Test Strips, and Lancets)
    5.2.5.2.2 By End User (Hospital Use and Home Use)
    5.2.5.2.3 By Company (Roche, Abbott, Johnson & Johnson and Others)
    5.2.5.3 Egypt (Market Size, Value, and Volume)
    5.2.5.3.1 By Component (Glucometer Devices, Test Strips, and Lancets)
    5.2.5.3.2 By End User (Hospital Use and Home Use)
    5.2.5.3.3 By Company (Roche, Abbott, Johnson & Johnson and Others)
    5.2.5.4 Oman (Market Size, Value, and Volume)
    5.2.5.4.1 By Component (Glucometer Devices, Test Strips, and Lancets)
    5.2.5.4.2 By End User (Hospital Use and Home Use)
    5.2.5.4.3 By Company (Roche, Abbott, Johnson & Johnson and Others)
    5.2.5.5 South Africa (Market Size, Value, and Volume)
    5.2.5.5.1 By Component (Glucometer Devices, Test Strips, and Lancets)
    5.2.5.5.2 By End User (Hospital Use and Home Use)
    5.2.5.5.3 By Company (Roche, Abbott, Johnson & Johnson and Others)
    5.2.5.6 Rest of Middle & Africa (Market Size, Value, and Volume)
    5.2.5.6.1 By Component (Glucometer Devices, Test Strips, and Lancets)
    5.2.5.6.2 By End User (Hospital Use and Home Use)
    5.2.5.6.3 By Company (Roche, Abbott, Johnson & Johnson and Others)

    6 MARKET INDICATORS
    6.1 Type-1 Diabetes Population (2012-2024)
    6.2 Type-2 Diabetes Population (2012-2024)

    7 COMPETITIVE LANDSCAPE
    7.1 COMPANY PROFILES
    7.1.1 Abbott Diabetes Care
    7.1.2 Roche
    7.1.3 Johnson & Johnson
    7.1.4 Arkray
    7.1.5 Ascensia Diabetes Care
    7.1.6 Agamatrix Inc.
    7.1.7 Bionime Corporation
    7.1.8 Acon
    7.1.9 Medisana
    7.1.10 Trivida
    7.1.11 Rossmax
    7.2 COMPANY SHARE ANALYSIS
    7.2.1 Roche
    7.2.2 Johnson & Johnson
    7.2.3 Abbott Diabetes Care
    7.2.4 Others

    8 MARKET OPPORTUNITIES AND FUTURE TRENDS

     

    Contact Us:

    Name: Ajay More

    Phone: US +14242530807/ UK +44 20 3239 8187

    Email: [email protected]

    Our Other Reports:

    Billiards Balls Market 2019 Industry Global Trends, Size, Comprehensive Research Study, Development Status, Opportunities, Future Plans, Competitive Landscape and Growth by Forecast 2026

    Global Enterprise Lecture Capture Service Market 2019: Industry Size & Share, Business Strategies, Growth Analysis, Regional Demand, Revenue, Key Manufacturers and 2024 Forecast Research Report,

    Road Marking Glass Beads Market 2019 | Global Industry Size, Share, Explosive Factors of Key Players, Future Trends and Industry Growth Rate Forecast to 2023

    Marketing Analytics Market 2019 Global Industry Trends, Statistics, Competition Strategies, Revenue Analysis, Key Players, Regional Analysis by Forecast to 2024

  • Be First to Comment

    Leave a Reply

    Your email address will not be published. Required fields are marked *